COVID-19 Update | November 20, 2020

COVID-19 News

COVID-19 Update | November 20, 2020

November 20, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of November 20, 2020. Notable advancements include:

  • Recent data from Moderna’s large trial indicates its COVID-19 vaccine candidate is 94.5% effective.
  • Pfizer plans to apply for emergency approval after its COVID-19 vaccine was 95 percent effective and had no serious side effects.
  • U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test for self-testing at home.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].